Publications:

Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors.

Journal For Immunotherapy Of Cancer

Ayeni, Deborah D; Miller, Braden B; Kuhlmann, Alexandra A; Ho, Ping-Chih PC; Robles-Oteiza, Camila C; Gaefele, Mmaserame M; Levy, Stellar S; de Miguel, Fernando J FJ; Perry, Curtis C; Guan, Tianxia T; Krystal, Gerald G; Lockwood, William W; Zelterman, Daniel D; Homer, Robert R; Liu, Zongzhi Z; Kaech, Susan S; Politi, Katerina K

Publication Date: 2019-07-10

Variant appearance in text: CD4: T70M

PubMed Link: 31291990

Variant Present in the following documents:

• Main text
• 40425_2019_Article_643.pdf

View BVdb publication page